SOD1 and eosinophilia-myalgia syndrome: To investigate the regulatory effect of ZSQYJDF on OS during EMs progression, we measured the serum levels of oxidative damage markers (MDA and 8-epi-PGF2α) and antioxidant enzymes (SOD and GSH-PX) in each group.